BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is involved in the development of FixVac product candidates, including BNT111, which is in a phase I clinical trial for advanced melanoma; BNT112 which is in a phase I/IIa trial for prostate cancer; BNT113, which is in a phase I/II trial to treat HPV+ head and neck cancers; BNT114 which is in a phase I clinical trial for triple negative breast cancer; BNT115 in a phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer; also develops neoantigen-specific immunotherapies, such as Autogene cevumeran (BNT122), which is in a phase II clinical trial for first-line melanoma, as well as a phase I clinical trial to treat multiple tumors intratumoral mRNA immunotherapy comprising SAR441000 which is in a phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. Additionally, the company develops RiboCytokines, including BNT151, BNT152 and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in a Phase I/II clinical trial to treat multiple solid tumors. In addition, he develops BNT321, an IgG1 monoclonal antibody, that it is in a phase I/IIa clinical trial for pancreatic cancer; BNT411, Small Molecule Immunomodulatory Product Candidate for Solid Tumors; prophylactic vaccine for COVID-19 and Influenza; and immunotherapies for infectious diseases and protein replacement therapies for rare diseases. The company has collaborations with Genentech, Inc.; Sanofi SA; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. and immunotherapies for infectious diseases and protein replacement therapies for rare diseases. The company has collaborations with Genentech, Inc.; Sanofi SA; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany. and immunotherapies for infectious diseases and protein replacement therapies for rare diseases. The company has collaborations with Genentech, Inc.; Sanofi SA; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
How to buy BioNTech SE (BNTX) shares – Step by step in Spanish
Interested in getting BioNTech SE (BNTX) shares on Nasdaq reliably and through a regulated broker in Europe? Do you like the fact that you can invest your profits per month and extract profits in the stock market? Today I am going to show you how you can sign up with degiro , a German regulated investment bank with low commissions, and how you can buy your first BioNTech SE (BNTX) share (BNTX) quickly and easily.
The method to follow is easy to perform :
- To begin we will register in DeGiro, an interface in which we will be able to buy shares of BioNTech SE (BNTX) (BNTX).
- Then we will enter money and make our 1st investment.
- As soon as we have the funds, we will have to locate BioNTech SE using the ticker, that is, BNTX.
- To finish we will have to add the number of shares that we will buy, the purchase value and the type of order.
It is possible that this checklist has not been a bit detailed for you, so I am going to show you step by step with images of each part:
How to register with the money broker
The first step is to register in Degiro from this link :
It will ask us for an email, a username and a PIN code to enter, and then we must continue with the link that they have sent us by email.
DeGiro will immediately ask us for some information of interest in order to approve our documentation . We must have on hand our passport number, DNI (identity document) or driving document, the telephone number and the bank account number that we will place to make our 1st deposit. If you don’t understand how this format works, you can check this simple tutorial article that we did at Educacep .
Once our account is accepted we will be able to put money from the Enter / Withdraw option. We will be able to make a bank transfer that will take 1-2 days, or we will be able to make the deposit instantly using Sofort, a totally secure and very reliable payment gateway.
How to buy BioNTech SE (BNTX) shares through DeGiro
As soon as we have the capital we will have the possibility of investing in our first action. You can select the place order button in the right corner or use the DEGIRO search engine and type in the ticker. In the following image you will see that I have written the Amazon Ticker but in your case you must enter (BNTX), the BioNTech SE ticker. As we are talking about an action, we will detect that the related results are listed and there we will see find BioNTech SE. The most essential thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case BioNTech SE (BNTX) is listed on Nasdaq. This step is very important so don’t get confused.
At the time of developing the order we have to pay special attention to what I will explain to you . We may place a limit or market order. Imagine that you want to buy a share of BioNTech SE at 206.14, but its price is currently much higher. With a limit order we are going to put the value at which we want to execute the acquisition and until there are no shares selling at a certain price, the purchase of the share will not be made. With a market order, Degiro will buy the number of shares that we have proposed at the true selling price, which will be very much in line with today’s trading price.
In both cases it is essential that you pay attention to the type of numbering: fixed or of the day . For example, in Spain, the stock market price is in the morning and until 1 in the afternoon, and in the US it corresponds to the afternoon schedule in Spain. If an order is permanent, it will continue until it reaches execution, but if you choose the “of the day” option, at the time the session ends, if it had not been carried out, it will be deleted from your history in Activity – Pending Orders.
I would like this simple text to help you buy shares in BioNTech SE. THANK YOU!
|Name||Title||Payment||exercised||Year of birth|
|Prof. Ugur Sahin MD||Co-Founder, CEO and Member of the Board of Directors||728.18k||N/A||1966|
|Prof. Christoph Hubert Huber||Co-Founder and Member of the Supervisory Board||N/A||N/A||1945|
|Dr. Sierk Poetting Ph.D.||CFO, MD, COO and member of the board of directors||734.21k||N/A||1974|
|Mr Ryan Richardson||Strategy Director, MD and member of the board of directors||647.41k||N/A||1980|
|Mr Sean Marett||Head of Bus. Director, Commercial Director and Member of the Board of Directors||812.57k||N/A||1966|
|Dr Ozlem Tureci||Medical director and member of the board of directors||720.95k||N/A||1968|
|Sylke Maas||Vice President of Investor Relations and Bus. Strategy||N/A||N/A||N/A|
|Dr. James Timothy Patrick Ryan Ph.D.||Vice President of Legal and Intellectual Property||N/A||N/A||N/A|
|Michael Boehler||MD and Head of Global External Communications||N/A||N/A||N/A|
|Katalin Kariko||Senior Vice President and Head of RNA Protein Replacement||N/A||N/A||N/A|
Recent BioNTech SE Events:
No events registered in Educacep